Vivekanandan Deepak Dev, Singh Nikita, Robaczewski Marshall, Wyer Abigayle, Canaan Lucas N, Whitson Daniel, Grabill Nathaniel, Louis Mena
General Surgery, Northeast Georgia Medical Center Gainesville, Gainesville, USA.
Internal Medicine, Albert Einstein College of Medicine, Jacobi Medical Center, Bronx, USA.
Cureus. 2024 Nov 28;16(11):e74681. doi: 10.7759/cureus.74681. eCollection 2024 Nov.
Coronary artery disease (CAD) remains a leading global cause of morbidity and mortality, underscoring the need for effective cardiovascular risk stratification and preventive strategies. Coronary artery calcium (CAC) scoring, traditionally performed using electrocardiogram (ECG)-gated cardiac computed tomography (CT) scans, has been widely validated as a robust tool for assessing cardiovascular risk. However, its application has been largely limited to high-risk populations due to the costs, technical requirements, and limited accessibility of cardiac CT scans. Recent advancements in artificial intelligence (AI) have introduced transformative opportunities to extend CAC detection to noncardiac CT scans, such as those performed for lung cancer screening, enabling broader and more accessible cardiovascular screening. This review provides a comprehensive analysis of AI-driven CAC detection, examining various types of AI models for CAC detection, like convolutional neural networks (CNNs) and U-Net architectures, and exploring the clinical, operational, and ethical implications of incorporating these technologies into routine practice. Technical challenges, including imaging variability, data privacy, and model bias, are discussed alongside essential areas for further research, such as standardization and validation across diverse populations. By leveraging widely available imaging data, AI-enabled CAC detection has the potential to advance preventive cardiology, supporting earlier risk identification, optimizing healthcare resources, and improving patient outcomes.
冠状动脉疾病(CAD)仍然是全球发病和死亡的主要原因,这凸显了有效进行心血管风险分层和预防策略的必要性。冠状动脉钙化(CAC)评分传统上使用心电图(ECG)门控心脏计算机断层扫描(CT)进行,已被广泛验证为评估心血管风险的可靠工具。然而,由于心脏CT扫描的成本、技术要求和可及性有限,其应用在很大程度上仅限于高危人群。人工智能(AI)的最新进展带来了变革性机遇,可将CAC检测扩展到非心脏CT扫描,如用于肺癌筛查的扫描,从而实现更广泛、更易获得的心血管筛查。本综述对人工智能驱动的CAC检测进行了全面分析,研究了用于CAC检测的各种人工智能模型,如卷积神经网络(CNN)和U-Net架构,并探讨了将这些技术纳入常规实践的临床、操作和伦理意义。还讨论了技术挑战,包括成像变异性、数据隐私和模型偏差,以及进一步研究的关键领域,如不同人群的标准化和验证。通过利用广泛可用的成像数据,人工智能驱动的CAC检测有潜力推动预防心脏病学的发展,支持早期风险识别、优化医疗资源并改善患者预后。